Jeffrey M. Leiden, Executive Chairman: Vertex Pharmaceuticals VRTX Sell · Filed 25/11/17

Trade details

Type: Insider sale
Amount: $14,192,630.2
Shares · price: 32,234 sh · $440.30 a share
Held after: 45,396 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Jeffrey M. LeidenExecutive Chairman
Trade date: 25/11/14
Filed: 25/11/17
Days to filing: 3 days

Sold 41.5% of holdings

Share of holding sold: 41.5%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/15~25/12/14

Jeffrey M. Leiden's recent trades

Jeffrey M. LeidenDirector
BuyOdyssey Therapeutics
Buy
Odyssey Therapeutics
ODTX
$100K
5,000 sh
$100K
Filed 05/11
Traded 05/08
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.1M
15,681 sh
$7.1M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$4.7M
10,360 sh
$4.7M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.5M
7,899 sh
$3.5M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.6M
5,880 sh
$2.6M
Filed 25/12/05
Traded 25/12/03

Jeffrey M. Leiden, Chairman — sold $14.2M of Vertex Pharmaceuticals VRTX · 41.5% of holdings · 10b5-1 plan | Whalegun